{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:08:23Z","timestamp":1760890103642,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejmech.2020.112615","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:27:49Z","timestamp":1594816069000},"page":"112615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c\u2019]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer\u2019s disease and other tauopathies"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2241-8611","authenticated-orcid":false,"given":"Emanuele","family":"Gabellieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-3206","authenticated-orcid":false,"given":"Francesca","family":"Capotosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Molette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nampally","family":"Sreenivasachary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-0398","authenticated-orcid":false,"given":"Mathias","family":"Berndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanno","family":"Schieferstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Varisco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Oden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Schmitt-Willich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludger","family":"Dinkelborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-6586","authenticated-orcid":false,"given":"Andrew","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Kroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"World Alzheimer Report 2016: Improving Healthcare for People Living with Dementia Coverage, Quality and Costs Now and in the Future","author":"Prince","key":"10.1016\/j.ejmech.2020.112615_bib2"},{"key":"10.1016\/j.ejmech.2020.112615_bib3","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and Down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112615_bib4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.1213210","article-title":"Functional links between A\u03b2 toxicity, endocytic trafficking, and Alzheimer\u2019s disease risk factors in yeast","volume":"334","author":"Treusch","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112615_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.trci.2016.07.001","article-title":"Alzheimer\u2019s drug-development pipeline: 2016","volume":"2","author":"Cummings","year":"2016","journal-title":"Alzheim. Dement."},{"key":"10.1016\/j.ejmech.2020.112615_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.113.136069","article-title":"Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers","volume":"55","author":"Shah","year":"2014","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112615_bib7","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1021\/jm5017544","article-title":"Tau positron emission tomography (PET) imaging: past, present, and future","volume":"58","author":"Ariza","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112615_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","article-title":"Tau PET imaging: present and future directions","volume":"12","author":"Saint-Aubert","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2020.112615_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer\u2019s disease","volume":"157","author":"Maass","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejmech.2020.112615_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3233\/JAD-170129","article-title":"PET Tau and amyloid-burden in mild Alzheimer\u2019s disease: divergent relationship with age, cognition,and cerebrospinal fluid biomarkers","volume":"60","author":"Koychev","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.ejmech.2020.112615_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112615_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004010000283","article-title":"Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick\u2019s disease, corticobasal degeneration and progressive supranuclear palsy","volume":"101","author":"Arai","year":"2001","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2020.112615_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00259-009-1293-8","article-title":"Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region","volume":"37","author":"Wong","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2020.112615_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2020.112615_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mcn.2018.12.001","article-title":"Biomarkers for tau pathology","volume":"97","author":"Schoell","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112615_bib16","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1021\/acs.jmedchem.8b01759","article-title":"Discovery of N-(4-[18F]fluoro-5-methylpyridin-2-yl)isoquinoline-6-amine (JNJ-64326067), a new promising tau positron emission tomography imaging tracer","volume":"62","author":"Rombouts","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112615_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-130098","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808","volume":"38","author":"Chien","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"year":"2015","series-title":"Deuterated Heterocyclic Compounds and Their Use as Imaging Agents","author":"Marik","key":"10.1016\/j.ejmech.2020.112615_bib18"},{"key":"10.1016\/j.ejmech.2020.112615_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.27271","article-title":"The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases","volume":"33","author":"Vermeiren","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejmech.2020.112615_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [18F]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marquie","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2020.112615_bib21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease","volume":"57","author":"Harada","year":"2016","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112615_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-017-0253-y","article-title":"Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain","volume":"9","author":"Ng","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ejmech.2020.112615_bib23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2967\/jnumed.117.196741","article-title":"Preclinical evaluation of 18F-RO6958948, 11C-RO6931643 and 11C-RO6924963 as novel radiotracers for imaging aggregated tau in Alzheimer\u2019s disease with positron emission tomography","volume":"59","author":"Honer","year":"2018","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmech.2020.112615_bib24","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [18F]PI-2620, a next generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2020.112615_bib25","first-page":"P177","article-title":"IC-P-217: preclinical and clinical characterization of 18F-PM-PBB3, a PET ligand for diverse tau pathologies","volume":"14","author":"Shimada","year":"2018","journal-title":"Alzheim. Dement."},{"key":"10.1016\/j.ejmech.2020.112615_bib26","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.oprd.9b00222","article-title":"A\u00a0short synthesis of the 2-bromo-N,9-dimethyl-6,7,8,9-tetrahydro-5H-pyrido[2,3-b]indol-6 amine building block","volume":"23","author":"Sreenivasachary","year":"2019","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2020.112615_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bmcl.2013.11.025","article-title":"Concise and high-yield synthesis of T808 and T808P for radiosynthesis of [18F]-T808, a PET tau tracer for Alzheimer\u2019s disease","volume":"24","author":"Gao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112615_bib28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1074\/jbc.M114.589309","article-title":"Conformation determines the seeding potencies of native and recombinant tau aggregates","volume":"290","author":"Falcon","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112615_bib29","article-title":"Imaging agents useful for identifying ad pathology","author":"Kolb","year":"2010","journal-title":"Patent"},{"key":"10.1016\/j.ejmech.2020.112615_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1021\/acschemneuro.6b00051","article-title":"Candidate PET radioligand development for neurofibrillary tangles: two distinct radioligand binding sites identified in postmortem Alzheimer\u2019s disease brain","volume":"7","author":"Cai","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112615_bib31","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/acschemneuro.8b00093","article-title":"Different PET tau tracers bind to multiple binding sites on the tau fibril: insight from computational modeling","volume":"9","author":"Murugan","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2020.112615_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nbt.1790","article-title":"Label-free quantification of membrane-ligand interactions using backscattering interferometry","volume":"29","author":"Baksh","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2020.112615_bib33","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112615_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/138920011794520044","article-title":"Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship","volume":"12","author":"Ma\u0161i\u010d","year":"2011","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2020.112615_bib35","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.bmcl.2015.05.035","article-title":"Fully automated synthesis of [(18)F]T807, a PET tau tracer for Alzheimer\u2019s disease","volume":"25","author":"Gao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112615_bib36","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F]T807, A novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheim. Dement."},{"key":"10.1016\/j.ejmech.2020.112615_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","article-title":"F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting A\u03b2 aggregates in the brain","volume":"32","author":"Zhang","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2020.112615_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13311-016-0490-y","article-title":"Tau imaging in Alzheimer\u2019s disease diagnosis and clinical trials","volume":"14","author":"Brosch","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2020.112615_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2020.112615_bib40","article-title":"Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins","author":"Kroth","year":"2015","journal-title":"Patent"},{"key":"10.1016\/j.ejmech.2020.112615_bib41","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"Conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer\u2019s disease","volume":"69","author":"Jicha","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2020.112615_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb0333s44","article-title":"Isolation and biochemical characterization of amyloid plaques and paired helical filaments","volume":"44","author":"Rostagno","year":"2009","journal-title":"Curr. Protoc. Cell Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420305870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:16:40Z","timestamp":1759328200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420305870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"alternative-id":["S0223523420305870"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112615","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c\u2019]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer\u2019s disease and other tauopathies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112615"}}